Ascentage Pharma Group International (HK:6855)
In a report issued on June 18, Guoyuan Securities (HK) Ltd from Guoyuan Securities (HK) maintained a Buy rating on Ascentage Pharma Group International, with a price target of HK$43.73. The company’s shares closed last Thursday at HK$32.70.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Ascentage Pharma Group International with a HK$65.76 average price target.
See the top stocks recommended by analysts >>
Kiora Pharmaceuticals (KPRX)
